Of the 86 patients with recurrent/metastatic breast cancer whose tumor samples were screened for PD-L1 expression (77 in nodal and soft tissue, 9 in liver tissue), 35 (40.7%) presented PD-L1 expression in stroma or at least 1% of tumor cells (as shown in Fig. 5a). This evidence concerns the gene CD274 and neoplasm.